SH30070.03 fetal bovine serum
Ended Awarded
- Contract number
- HHSN261NDP68392
- Awardee
-
Hyclone Laboratories, Inc. UEI MLDFDVFYHWG3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,520
Award facts
- Contract value
-
- $2,520.00 Current, with exercised options
- $0.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Not on record Potential, with all options
- Funding agency
- Office of the Director National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- 0 offers Simplified Acquisition
- Pricing
- Other
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN261NDP68392?
HHSN261NDP68392 was awarded to Hyclone Laboratories, Inc. by National Cancer Institute (National Institutes of Health) on September 21, 2005.
How much is contract HHSN261NDP68392 worth?
The government has obligated $2,520 on HHSN261NDP68392.
Which agency awarded contract HHSN261NDP68392?
National Cancer Institute (National Institutes of Health) awarded HHSN261NDP68392, with funding from Office of the Director (National Institutes of Health).
Is contract HHSN261NDP68392 an order under another contract?
Yes. HHSN261NDP68392 is a BPA call under HHSN263200200056813B, a blanket purchase agreement.
Was contract HHSN261NDP68392 competed?
The government received 0 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award